logo-loader
viewLexaria Bioscience Corp.

Lexaria Bioscience agrees to sell non-pharmaceutical THC related assets for 3.85 million

Lexaria Bioscience (CSE: LXX- OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive with news the company has agreed to sell certain non-core, non-pharmaceutical THC-related business assets to Hill Street Beverage for 3.85 million Canadian.

Bunka also told Proactive “Hill Street is acquiring royalty-free and perpetual global rights including relicensing rights of Lexaria's DehydraTECH technology” He also said Lexaria retains full ownership of its DehydraTECH technology.

Quick facts: Lexaria Bioscience Corp.

Price: 0.27 CAD

CSE:LXX
Market: CSE
Market Cap: $24.31 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp. named herein, including the promotion by the Company of Lexaria Bioscience Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Lexaria Bioscience sees positive results from study using DehydraTECH Technology

Lexaria Bioscience (CSE:LXX-OTCQX:LXRP) President John Docherty joined Steve Darling from Proactive Investors Vancouver to talk about a recent controlled, double-blinded European human clinical study that evaluated TurboCBD, Lexaria’s  DehydraTECH powered, cannabidiol fortified hemp-oil...

on 22/2/19

2 min read